Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was USD 0.58239 million compared to USD 0.037763 million a year ago. Net loss was USD 0.677701 million compared to USD 1.31 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.